Get 20% lifetime commission for referring investors to digrin.com
here.
IGC Pharma, Inc. ( IGC) - Key Metrics
IGC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0 | -$0.03 | $0.01 | $0.01 |
| 2026Q4 | $0 | -$0.03 | -$0.01 | -$0.01 |
| 2026Q3 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2026Q2 | $0 | -$0.02 | -$0.02 | -$0.02 |
| 2026Q1 | $0 | -$0.02 | -$0.02 | -$0.02 |
IGC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -2.32 |
| 2026Q4 | 0% | -2.60 |
| 2026Q3 | 0% | -9.26 |
| 2026Q2 | 0% | -5.19 |
| 2026Q1 | 0% | -3.96 |
IGC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2027Q1 | 5.10% | 0% |
| 2026Q4 | -5.57% | 0% |
| 2026Q3 | -4.62% | 0% |
| 2026Q2 | -5.62% | 0% |
| 2026Q1 | -6.02% | 0% |
IGC
Price: $0.25
52 week price:
Earnings Per Share: -0.06 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 122069
Market Capitalization: 28.0 million